When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Novartis Q3 Earnings Beats Expectations On Strong Sales ... - AOL

   www.aol.com/novartis-q3-earnings-beats...

   On Tuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% on constant currency), beating the consensus of $12.76 billion. Volume contributed 12 percentage ...

3. Top Stock Reports for Novartis, Zoom Video & Caterpillar - AOL

   www.aol.com/news/top-stock-reports-novartis-zoom...

   For premium support please call: 800-290-4726 more ways to reach us

4. Why Novartis Stock Is Down Today Despite Topping Q2 ... - AOL

   www.aol.com/why-novartis-stock-down-today...

   For premium support please call: 800-290-4726 more ways to reach us

5. Is Novartis (NVS) a Great Value Stock Right Now? - AOL

   www.aol.com/news/novartis-nvs-great-value-stock...

   For premium support please call: 800-290-4726 more ways to reach us

6. Novartis Elevates Midterm Sales Forecast, CEO Highlights ...

   www.aol.com/novartis-elevates-midterm-sales...

   On Thursday, Novartis AG (NYSE:NVS) raised its mid-term sales guidance, increasing its compound annual growth rate (CAGR) target to 6% from 5% for 2023-2028. The upgrade reflects performance from ...

7. Novartis AG Stock Appears To Be Fairly Valued - AOL

   www.aol.com/news/novartis-ag-stock-appears...

   The stock of Novartis AG (NYSE:NVS, 30-year Financials) is estimated to be fairly valued, according to GuruFocus Value calculation.

8. List of largest biomedical companies by market capitalization

   en.wikipedia.org/wiki/List_of_largest_biomedical...

   The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

9. Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates - AOL

   www.aol.com/news/novartis-nvs-q3-earnings-line...

   Novartis (NVS) beats sales estimates in Q3, driven by Cosentyx and Entresto, while earnings came in line. The company plans to acquire Endocyte to broaden its oncology pipeline.